Weizhou Zhang, Ph.D.
Affiliations: | 2006 | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Cell Biology, Microbiology BiologyGoogle:
"Weizhou Zhang"Parents
Sign in to add mentor| Lu-Hai Wang | grad student | 2006 | Mount Sinai School of Medicine | |
| (RACK1-mediated novel signaling pathways in growth and apoptosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kolb R, Zhang W. (2020) Obesity and Breast Cancer: A Case of Inflamed Adipose Tissue. Cancers. 12 |
| Kluz PN, Kolb R, Xie Q, et al. (2020) Cancer cell-intrinsic function of CD177 in attenuating β-catenin signaling. Oncogene |
| Liu Q, Borcherding NC, Shao P, et al. (2020) Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance. Ebiomedicine. 51: 102612 |
| Vishwakarma A, Bocherding N, Chimenti M, et al. (2020) Abstract A80: Mapping immune landscape in clear cell renal carcinoma by single-cell genomics Cancer Immunology Research. 8 |
| Wu VT, Kiriazov B, Koch KE, et al. (2019) A TFAP2C Gene Signature is Predictive of Outcome in HER2-positive Breast Cancer. Molecular Cancer Research : McR |
| Liu Q, Borcherding N, Shao P, et al. (2019) Identification of novel TGF-β regulated genes with pro-migratory roles. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 165537 |
| Pandey G, Borcherding N, Kolb R, et al. (2019) ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers. 11 |
| Vikas P, Borcherding N, Zhang W. (2018) The clinical promise of immunotherapy in triple-negative breast cancer. Cancer Management and Research. 10: 6823-6833 |
| Kolb R, Kluz P, Tan ZW, et al. (2018) Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene |
| Borcherding N, Cole K, Kluz P, et al. (2018) Reevaluating E-cadherin and β-catenin: A pan-cancer proteomic approach with an emphasis on breast cancer. The American Journal of Pathology |